Performance of bleeding risk scores in dialysis patients

被引:33
|
作者
Ocak, Gurbey [1 ]
Ramspek, Chava [2 ]
Roolunaaker, Maarten B. [1 ]
Blankestijn, Peter J. [1 ]
Verhaar, Marianne C. [1 ]
Bos, Willem Jan W. [3 ]
Dekker, Friedo W. [2 ]
van Diepen, Merel [2 ]
机构
[1] Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands
[2] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands
[3] St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands
关键词
ATRIA; dialysis; HASBLED; HEMORR2HAGES; ORBIT; HAS-BLED SCORE; ATRIAL-FIBRILLATION; ANTICOAGULATED PATIENTS; HEMODIALYSIS-PATIENTS; CHA(2)DS(2)-VASC SCORES; MULTIPLE IMPUTATION; WARFARIN INITIATION; PREDICTIVE ABILITY; ISCHEMIC-STROKE; HEMORRHAGE;
D O I
10.1093/ndt/gfy387
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background Bleeding risk scores have been created to identify patients with an increased bleeding risk, which could also be useful in dialysis patients. However, the predictive performances of these bleeding risk scores in dialysis patients are unknown. Therefore, the aim of this study was to validate existing bleeding risk scores in dialysis patients. Methods A cohort of 1745 incident dialysis patients was prospectively followed for 3 years during which bleeding events were registered. We evaluated the discriminative performance of the Hypertension, Abnormal kidney and liver function, Stroke, Bleeding, Labile INR, Elderly and Drugs or alcohol (HASBLED), the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA), the Hepatic or kidney disease, Ethanol abuse, Malignancy, Older age, Reduced platelet count or Reduced platelet function, Hypertension, Anaemia, Genetic factors, Excessive fall risk and Stroke (HEMORR2HAGES) and the Outcomes Registry for Better Informed Treatment (ORBIT) bleeding risk scores by calculating C-statistics with 95% confidence intervals (CI). In addition, calibration was evaluated by comparing predicted and observed risks. Results Of the 1745 dialysis patients, 183 patients had a bleeding event, corresponding to an incidence rate of 5.23/100 person-years. The HASBLED [C-statistic of 0.58 (95% CI 0.54-0.62)], ATRIA [C-statistic of 0.55 (95% CI 0.51-0.60)], HEMORR2HAGES [C-statistic of 0.56 (95% CI 0.52-0.61)] and ORBIT [C-statistic of 0.56 (95% CI 0.52-0.61)] risk scores had poor discriminative performances in dialysis patients. Furthermore, the calibration analyses showed that patients with a low risk of bleeding according to the HASBLED, ATRIA, HEMORR2HAGES and ORBIT bleeding risk scores had higher incidence rates for bleeding in our cohort than predicted. Conclusions The HASBLED, ATRIA, HEMORR2HAGES and ORBIT bleeding risk scores had poor predictive abilities in dialysis patients. Therefore, these bleeding risk scores may not be useful in this population.
引用
收藏
页码:1223 / 1231
页数:9
相关论文
共 50 条
  • [31] Performance of risk scores in predicting major bleeding in left ventricular assist device recipients: a comparative external validation
    van der Horst, S. F. B.
    de Jong, Y.
    van Rein, N.
    Jukema, J. W.
    Palmen, M.
    Janssen, E.
    Bonneville, E. F.
    Klok, F. A.
    V. Huisman, M.
    Tops, L. F.
    den Exter, P. L.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (04)
  • [32] Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation
    Tan, Jingwen
    Bae, Sunjae
    Segal, Jodi B.
    Zhu, Junya
    Alexander, G. Caleb
    Segev, Dorry L.
    McAdams-DeMarco, Mara
    NEPHROLOGY, 2019, 24 (02) : 234 - 244
  • [33] Comparison of clinical performance of four gastrointestinal bleeding risk scores in Chinese patients with atrial fibrillation receiving oral anticoagulants
    Mei-na Lv
    Xiao-chun Zheng
    Hong-qin Zhang
    Fang-da Xu
    Ting-ting Wu
    Wen-jun Chen
    Xiao-tong Xia
    Jing-lan Fu
    Shao-jun Jiang
    Jin-hua Zhang
    Journal of Thrombosis and Thrombolysis, 2021, 51 : 136 - 142
  • [34] Bleeding Risk in Patients with Cancer
    Englisch, Cornelia
    Vladic, Nikola
    Ay, Cihan
    HAMOSTASEOLOGIE, 2024,
  • [35] Comparison of Bleeding Risk Scores in Elderly Patients Receiving Extended Anticoagulation with Vitamin K Antagonists for Venous Thromboembolism
    Frei, Andrea N.
    Stalder, Odile
    Limacher, Andreas
    Mean, Marie
    Baumgartner, Christine
    Rodondi, Nicolas
    Aujesky, Drahomir
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (11) : 1512 - 1522
  • [36] GASTROINTESTINAL-BLEEDING IN DIALYSIS PATIENTS
    DOHERTY, CC
    NEPHRON, 1993, 63 (02) : 132 - 139
  • [37] Optimal Choice of Pharmacological Therapy - Prevention of Stroke and Assessment of Bleeding Risk in Patients with Atrial Fibrillation
    Hodzic, Enisa
    Begic, Edin
    Zuhric, Sedina
    Nalbantic, Azra Durak
    Begic, Zijo
    Masic, Izet
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2019, 10 : 1 - 7
  • [38] Mortality due to bleeding, myocardial infarction and stroke in dialysis patients
    Ocak, G.
    Noordzij, M.
    Rookmaaker, M. B.
    Cases, A.
    Couchoud, C.
    Heaf, J. G.
    Jarraya, F.
    De Meester, J.
    Groothoff, J. W.
    Waldum-Grevbo, B. E.
    Palsson, R.
    Resic, H.
    Remon, C.
    Finne, P.
    Stendahl, M.
    Verhaar, M. C.
    Massy, Z. A.
    Dekker, F. W.
    Jager, K. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (10) : 1953 - 1963
  • [39] Bleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores
    van Es, Nick
    Wells, Philip S.
    Carrier, Marc
    THROMBOSIS RESEARCH, 2017, 152 : 52 - 60
  • [40] Predictive ability of scores for bleeding risk in heart disease outpatients on warfarin in Brazil
    de Queiroz Oliveira, Joao Antonio
    Pinho Ribeiro, Antonio Luiz
    Ribeiro, Daniel Dias
    Nobre, Vandack
    da Costa Rocha, Manoel Otavio
    Parreiras Martins, Maria Auxiliadora
    PLOS ONE, 2018, 13 (10):